Ownership Filing by Choo Chee Kong

This filing details the ownership of CytoMed Therapeutics Ltd (GDTC) by Choo Chee Kong. As of March 18, 2026, Mr. Choo directly owns 318,324 ordinary shares. Additionally, he indirectly owns 2,075,310 ordinary shares through his 55% ownership of Glorious Finance Limited and a further 194,112 ordinary shares through EP Capital Inc. Mr. Choo is identified as a director and a greater than 10% owner of the company. The report was signed on May 15, 2026.